|
Volumn 27, Issue 10, 2006, Pages 1131-1132
|
The decrease in healthcare-associated methicillin-resistant Staphylococcus aureus infections and savings from glycopeptide use
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
GLYCOPEPTIDE;
TEICOPLANIN;
VANCOMYCIN;
ARTICLE;
BACTERIAL INFECTION;
COST BENEFIT ANALYSIS;
DISEASE CONTROL;
HEALTH CARE;
HEALTH CENTER;
HOSPITAL PHARMACY;
HUMAN;
INFECTION CONTROL;
MEDICAL EDUCATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
TURKEY (REPUBLIC);
CROSS INFECTION;
GLYCOPEPTIDES;
HUMANS;
METHICILLIN RESISTANCE;
STAPHYLOCOCCAL INFECTIONS;
TURKEY;
|
EID: 33750571177
PISSN: 0899823X
EISSN: None
Source Type: Journal
DOI: 10.1086/507969 Document Type: Article |
Times cited : (3)
|
References (7)
|